https://onkocalendar.com/ https://onkocalendar.com/novini/cipla-qilu-ql2107-pembrolizumab-biosimilar 2026-09-04T06:06:57.771Z https://onkocalendar.com/novini/etentamig-cervino-phase-iii-mnozhestven-mielom 2026-09-04T06:07:35.807Z https://onkocalendar.com/novini/tensive-eib-regenera-rekonstruktsia-rak-na-gardata 2026-09-04T06:08:12.571Z https://onkocalendar.com/novini/gsk-hutchmed-hmpl-a830-kras-egfr-attc 2026-09-03T09:40:08.013Z https://onkocalendar.com/novini/ivonescimab-harmoni2-os-pdl1-nsclc 2026-09-03T09:41:11.549Z https://onkocalendar.com/novini/tscan-sprya-phase-iii-alloha2-tsc101 2026-09-03T09:41:25.869Z https://onkocalendar.com/novini/norroy-177lu-nym032-phase-iii-mcrpc 2026-09-04T06:08:34.574Z https://onkocalendar.com/novini/tqb2102-phase-iii-her2-low-rak-na-gardata 2026-09-03T09:41:37.204Z https://onkocalendar.com/novini/telix-bipass-phase-iii-psma-pet-predi-biopsia 2026-09-03T09:42:29.561Z https://onkocalendar.com/novini/fda-breakthrough-jbs003-hpv-orofaringealen-rak 2026-09-02T06:11:57.923Z https://onkocalendar.com/novini/plixorafenib-forte-braf-fusion-mezhdinen-analiz 2026-09-02T06:10:04.236Z https://onkocalendar.com/novini/astrazeneca-zegfrovy-globalen-licenz-egfr-exon20-nsclc 2026-09-02T06:08:49.962Z https://onkocalendar.com/novini/eu-odobri-enhertu-pertuzumab-her2-metastatichen-rak-na-gardata 2026-09-02T06:06:27.706Z https://onkocalendar.com/novini/tagrisso-orpathys-sanovo-phase-iii-egfr-met-nsclc 2026-09-03T09:42:54.713Z https://onkocalendar.com/novini/rezatapopt-pynnacle-ovarialen-rak-nda-2027 2026-09-01T08:00:07.945Z https://onkocalendar.com/novini/alpha-dart-impact-pankreas-pivotal-programa 2026-09-01T08:00:35.168Z https://onkocalendar.com/novini/ziihera-herizon-gea01-os-her2-gastroezofagealen-rak 2026-09-01T08:00:58.601Z https://onkocalendar.com/novini/ide849-fda-phase-iii-es-sclc 2026-09-01T08:01:21.641Z https://onkocalendar.com/novini/dualitybio-genentech-dupac-adc-sdelka 2026-08-30T02:49:01.256Z https://onkocalendar.com/novini/fda-odobri-rusfertide-policitemia-vera 2026-08-29T06:19:32.792Z https://onkocalendar.com/novini/dawn-303-incb161734-kras-g12d-rak-na-pankreasa 2026-08-29T06:19:41.067Z https://onkocalendar.com/novini/biontech-prekrati-mrna-izpitvane-ctdna-kolorektalen-rak 2026-08-29T06:20:03.188Z https://onkocalendar.com/novini/tissue-free-ctdna-mrd-ranen-tnbc 2026-08-28T06:15:59.472Z https://onkocalendar.com/novini/formosa-eu-cta-tsy110-kadcyla-biosimilar 2026-08-31T06:24:29.028Z https://onkocalendar.com/novini/fda-odobri-daraxonrasib-metastatichen-rak-na-pankreasa%20-%201 2026-08-27T12:51:21.934Z https://onkocalendar.com/novini/soquelitinib-phase-iii-periferen-t-kletachen-limfom 2026-08-28T06:16:08.572Z https://onkocalendar.com/novini/fda-roche-her2-companion-diagnostics-gastroezofagealen-rak 2026-08-29T14:36:30.883Z https://onkocalendar.com/novini/bexar-bexmarilimab-doxorubicin-metastatichen-sarkom 2026-08-29T14:36:42.360Z https://onkocalendar.com/novini/oncoinvent-radspherin-phase-ii-ovarialen-rak 2026-08-29T14:37:02.414Z https://onkocalendar.com/novini/ruxotemitide-phase-iii-visokoriskov-rezektabilen-melanom 2026-08-28T06:19:20.649Z https://onkocalendar.com/novini/ec-tecvayli-daratumumab-vtora-linia-mnozhestven-mielom 2026-08-31T06:25:03.570Z https://onkocalendar.com/novini/fda-odobri-daraxonrasib-metastatichen-rak-na-pankreasa 2026-08-28T06:19:29.782Z https://onkocalendar.com/novini/ivonescimab-harmoni-phase-iii-egfr-nsclc 2026-08-29T14:36:52.283Z https://onkocalendar.com/novini/fda-zanidatamab-tislelizumab-her2-gastroezofagealen-adenokarcinom 2026-08-28T06:19:37.126Z https://onkocalendar.com/novini/fda-prioriteten-pregled-jemperli-dmmr-msih-rak-rektum 2026-08-30T02:49:17.792Z https://onkocalendar.com/novini/intismeran-autogene-phase-iii-rezetsiran-melanom 2026-08-29T06:20:14.473Z https://onkocalendar.com/novini/immatics-suprame-phase-iii-anzu-cel-prame-melanom 2026-08-30T02:49:28.165Z https://onkocalendar.com/novini/rad101-pivotal-phase-iii-mozachni-metastazi 2026-08-30T02:49:43.037Z https://onkocalendar.com/novini/enhertu-destiny-lung04-her2-mutiral-nsclc 2026-08-29T06:20:23.555Z https://onkocalendar.com/novini/tagrisso-orpathys-saffron-phase-iii-egfr-met-nsclc 2026-08-29T14:37:14.187Z https://onkocalendar.com/novini/astrazeneca-prekrati-evolve-lung02-volrustomig-nsclc 2026-08-30T02:48:45.714Z https://onkocalendar.com/novini/fda-iberdomide-daratumumab-mnozhestven-mielom 2026-08-31T06:24:47.748Z https://onkocalendar.com/novini/lacutamab-tellomak3-phase-iii-ctcl 2026-09-01T08:01:45.790Z https://onkocalendar.com/novini/fda-tudriqev-nivolumab-refrakteren-melanom 2026-08-31T06:25:16.908Z https://onkocalendar.com/novini/kandlelit013-calderasib-phase-iii-adjuvanten-nsclc 2026-08-31T06:25:31.930Z